The Independent Voice of
European Private Equity

Advanced Search

Maven invests in Alzheimer’s disease testing company

olly.jackson@realdealsmedia.com 7 August 2019

Maven has invested in Cytox, a UK-based company that specialises in the genetic testing for Alzheimer’s disease.

Next article »

« Previous article

Related Articles

Bridgepoint invests in French risk manager Forward Global

02/05/24

Bruin Capital extends sports focus with acquisition of tech firm PlayGreen

02/05/24

BGF exits engineering design company Hydrock

02/05/24

Afinum exits IT services firm FAST LTA

02/05/24

Inflexion reaps over 6x return from exit of automotive tech company

02/05/24

Family law lender Level raises £10m

02/05/24